Al Amirsadeghi
Cello Therapeutics, USA
Biography
Al Amirsadeghi has completed his Ph.D in year 2013 from the mechanical engineering department of Louisiana State University. After graduation he joined TEVA Pharmaceuticals where he developed a microfluidic based platform technology capable of mass production of narrowly distributed, polymeric micro-particles for drug delivery applications. He used this technology to develop preclinical depot formulations for various indications. Some of these formulations are poised to enter clinical studies in the near future. In 2017 he joined Cello Therapeutics to work on early stage development of human red blood cell coated nano-particles for passive and active targeting of cancerous cells. He has published more than 21 papers and conference proceedings in reputed journals and conferences.